celecoxib has been researched along with methylcellulose in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (45.45) | 29.6817 |
2010's | 5 (45.45) | 24.3611 |
2020's | 1 (9.09) | 2.80 |
Authors | Studies |
---|---|
Araman, A; Değim, T; Gönüllü, U; Uner, M; Yener, G | 1 |
Chandran, S; Ravi, P; Saha, RN | 1 |
Chowdary, KP; Srinivas, SV | 1 |
Gupta, VR; Jani, GK; Mutalik, S; Patel, MM | 1 |
Albers, J; Alles, R; Kleinebudde, P; Knop, K; Matthée, K; Nahrup, JS | 1 |
Hao, Y; Jiang, T; Liu, Y; Sun, C; Wang, S; Zheng, L | 1 |
Chan, C; Chiang, PC; Chou, KJ; Cui, Y; Hart, R; Ran, Y; Sambrone, A | 1 |
Taylor, LS; Xie, T | 2 |
Back, K; Bungay, P; Davis, J; Flanagan, N; Hudson, R; Lainé, AL; Price, D; Roberts, D | 1 |
Bristol, AN; Lamm, MS; Li, Y | 1 |
11 other study(ies) available for celecoxib and methylcellulose
Article | Year |
---|---|
Effect of vehicles and penetration enhancers on the in vitro percutaneous absorption of celecoxib through human skin.
Topics: Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Emulsions; Gels; Humans; In Vitro Techniques; Isoenzymes; Lactose; Membrane Proteins; Methylcellulose; Ointments; Oxazines; Pharmaceutical Vehicles; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Skin Absorption; Solubility; Spectrophotometry, Ultraviolet; Sulfonamides | 2003 |
Development and in vitro evaluation of oral controlled release formulations of celecoxib using optimization techniques.
Topics: Celecoxib; Cellulose; Chemistry, Pharmaceutical; Delayed-Action Preparations; Lactose; Methylcellulose; Pyrazoles; Solubility; Sulfonamides; Tablets; Technology, Pharmaceutical | 2006 |
Influence of hydrophilic polymers on celecoxib complexation with hydroxypropyl beta-cyclodextrin.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Anti-Inflammatory Agents, Non-Steroidal; beta-Cyclodextrins; Calorimetry, Differential Scanning; Celecoxib; Chemistry, Pharmaceutical; Hypromellose Derivatives; Methylcellulose; Polymers; Povidone; Pyrazoles; Solubility; Sulfonamides; X-Ray Diffraction | 2006 |
Spherical crystals of celecoxib to improve solubility, dissolution rate and micromeritic properties.
Topics: Calorimetry, Differential Scanning; Celecoxib; Chemistry, Pharmaceutical; Crystallization; Cyclooxygenase Inhibitors; Kinetics; Methylcellulose; Microscopy, Electron, Scanning; Particle Size; Pharmaceutic Aids; Powders; Pyrazoles; Solubility; Spectrophotometry, Infrared; Sulfonamides; Technology, Pharmaceutical; Water; X-Ray Diffraction | 2007 |
Mechanism of drug release from polymethacrylate-based extrudates and milled strands prepared by hot-melt extrusion.
Topics: Calorimetry, Differential Scanning; Celecoxib; Chemistry, Pharmaceutical; Crystallization; Cyclooxygenase Inhibitors; Drug Carriers; Drug Stability; Drug Storage; Excipients; Hypromellose Derivatives; Methylcellulose; Polymethacrylic Acids; Pyrazoles; Solubility; Sulfonamides; Temperature; Transition Temperature; X-Ray Diffraction | 2009 |
Mechanism of dissolution enhancement and bioavailability of poorly water soluble celecoxib by preparing stable amorphous nanoparticles.
Topics: Administration, Oral; Animals; Area Under Curve; Biological Availability; Celecoxib; Chemical Precipitation; Cyclooxygenase 2 Inhibitors; Dogs; Drug Stability; Drug Storage; Excipients; Female; Hydrogen Bonding; Hypromellose Derivatives; Male; Methylcellulose; Nanoparticles; Particle Size; Pyrazoles; Sodium Dodecyl Sulfate; Solubility; Solvents; Sonication; Sulfonamides | 2010 |
Evaluation of drug load and polymer by using a 96-well plate vacuum dry system for amorphous solid dispersion drug delivery.
Topics: Acetaminophen; Celecoxib; Chemistry, Pharmaceutical; Crystallization; Drug Carriers; Drug Stability; Equipment Design; Griseofulvin; High-Throughput Screening Assays; Hypromellose Derivatives; Indomethacin; Kinetics; Methylcellulose; Miniaturization; Pharmaceutical Preparations; Polymers; Povidone; Pyrazoles; Quality Control; Reproducibility of Results; Solubility; Solvents; Sulfonamides; Technology, Pharmaceutical; Vacuum; Water | 2012 |
Dissolution Performance of High Drug Loading Celecoxib Amorphous Solid Dispersions Formulated with Polymer Combinations.
Topics: Celecoxib; Chemistry, Pharmaceutical; Crystallization; Drug Stability; Kinetics; Methylcellulose; Polymers; Povidone; Solubility; Solutions; Spectrum Analysis, Raman | 2016 |
Improved Release of Celecoxib from High Drug Loading Amorphous Solid Dispersions Formulated with Polyacrylic Acid and Cellulose Derivatives.
Topics: Acrylic Resins; Celecoxib; Chemistry, Pharmaceutical; Drug Carriers; Drug Compounding; Drug Stability; Hypromellose Derivatives; Methylcellulose; Polymers; Solubility | 2016 |
Enhanced oral delivery of celecoxib via the development of a supersaturable amorphous formulation utilising mesoporous silica and co-loaded HPMCAS.
Topics: Administration, Oral; Animals; Biological Availability; Celecoxib; Drug Compounding; Drug Liberation; Male; Methylcellulose; Rats; Silicon Dioxide; Solubility | 2016 |
Impact of Hydroxypropyl Methylcellulose Acetate Succinate Critical Aggregation Concentration on Celecoxib Supersaturation.
Topics: Celecoxib; Chemical Precipitation; Crystallization; Magnetic Resonance Spectroscopy; Methylcellulose; Solubility; Spectrometry, Fluorescence | 2021 |